PGC-1α and PGC-1β increase CrT expression and creatine uptake in myotubes via ERRα

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 12, 2014, Pages 2937-2943

  Brown, Erin L ^a   Snow, Rod J ^a   Wright, Craig R ^a   Cho, Yoshitake ^b   Wallace, Marita A ^a   Kralli, Anastasia ^b   Russell, Aaron P ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Creatine; Creatine transporter; ERR ; PGC 1 ; PGC 1 ; Skeletal muscle

Indexed keywords

CREATINE; ESTROGEN RELATED RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CRT GENE; GENE; GENE EXPRESSION; INTRON; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN MOTIF; RAT; SKELETAL MUSCLE;

EID: 84907459151     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.08.010     Document Type: Article

References (60)

1. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 2000, 80:1107-1213.
2. Green A.L., Hultman E., Macdonald I.A., Sewell D.A., Greenhaff P.L. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am. J. Physiol. 1996, 271:E821-E826.
3. Nabuurs C.I., Choe C.U., Veltien A., Kan H.E., van Loon L.J., Rodenburg R.J., Matschke J., Wieringa B., Kemp G.J., Isbrandt D., Heerschap A. Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake. J. Physiol. 2013, 591:571-592.
4. Becque M.D., Lochmann J.D., Melrose D.R. Effects of oral creatine supplementation on muscular strength and body composition. Med. Sci. Sports Exerc. 2000, 32:654-658.
5. Candow D.G., Chilibeck P.D., Burke D.G., Mueller K.D., Lewis J.D. Effect of different frequencies of creatine supplementation on muscle size and strength in young adults. J. Strength Cond. Res. 2011, 25:1831-1838.
6. Tarnopolsky M.A., Mahoney D.J., Vajsar J., Rodriguez C., Doherty T.J., Roy B.D., Biggar D. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 2004, 62:1771-1777.
7. Chung Y.L., Alexanderson H., Pipitone N., Morrison C., Dastmalchi M., Stahl-Hallengren C., Richards S., Thomas E.L., Hamilton G., Bell J.D., Lundberg I.E., Scott D.L. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007, 57:694-702.
8. Passaquin A.C., Renard M., Kay L., Challet C., Mokhtarian A., Wallimann T., Ruegg U.T. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul. Disord. 2002, 12:174-182.
9. Guerrero-Ontiveros M.L., Wallimann T. Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol. Cell. Biochem. 1998, 184:427-437.
10. Brault J.J., Abraham K.A., Terjung R.L. Muscle creatine uptake and creatine transporter expression in response to creatine supplementation and depletion. J. Appl. Physiol. 2003, 94:2173-2180.
11. Loike J.D., Zalutsky D.L., Kaback E., Miranda A.F., Silverstein S.C. Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:807-811.
12. Odoom J.E., Kemp G.J., Radda G.K. The regulation of total creatine content in a myoblast cell line. Mol. Cell. Biochem. 1996, 158:179-188.
13. Alfieri R.R., Bonelli M.A., Cavazzoni A., Brigotti M., Fumarola C., Sestili P., Mozzoni P., De Palma G., Mutti A., Carnicelli D., Vacondio F., Silva C., Borghetti A.F., Wheeler K.P., Petronini P.G. Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress. J. Physiol. 2006, 576:391-401.
14. Dai W., Vinnakota S., Qian X., Kunze D.L., Sarkar H.K. Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes. Arch. Biochem. Biophys. 1999, 361:75-84.
15. Darrabie M.D., Arciniegas A.J., Mishra R., Bowles D.E., Jacobs D.O., Santacruz L. AMPK and substrate availability regulate creatine transport in cultured cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E870-E876.
16. Shojaiefard M., Christie D.L., Lang F. Stimulation of the creatine transporter SLC6A8 by the protein kinases SGK1 and SGK3. Biochem. Biophys. Res. Commun. 2005, 334:742-746.
17. Shojaiefard M., Christie D.L., Lang F. Stimulation of the creatine transporter SLC6A8 by the protein kinase mTOR. Biochem. Biophys. Res. Commun. 2006, 341:945-949.
18. Wang W., Jobst M.A., Bell B., Zhao C.R., Shang L.H., Jacobs D.O. Cr supplementation decreases tyrosine phosphorylation of the CreaT in skeletal muscle during sepsis. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1046-E1054.
19. Derave W., Straumann N., Olek R.A., Hespel P. Electrolysis stimulates creatine transport and transporter cell surface expression in incubated mouse skeletal muscle: potential role of ROS. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1250-E1257.
20. Tran T.T., Dai W., Sarkar H.K. Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J. Biol. Chem. 2000, 275:35708-35714.
21. Tarnopolsky M.A., Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve 1999, 22:1228-1233.
22. Tarnopolsky M.A., Parshad A., Walzel B., Schlattner U., Wallimann T. Creatine transporter and mitochondrial creatine kinase protein content in myopathies. Muscle Nerve 2001, 24:682-688.
23. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor Estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 2003, 278:9013-9018.
24. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 2007, 5:345-356.
25. Mootha V.K., Handschin C., Arlow D., Xie X., St Pierre J., Sihag S., Yang W., Altshuler D., Puigserver P., Patterson N., Willy P.J., Schulman I.G., Heyman R.A., Lander E.S., Spiegelman B.M. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6570-6575.
26. Handschin C., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006, 27:728-735.
27. Huss J.M., Torra I.P., Staels B., Giguere V., Kelly D.P. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 2004, 24:9079-9091.
28. Schreiber S.N., Emter R., Hock M.B., Knutti D., Cardenas J., Podvinec M., Oakeley E.J., Kralli A. The Estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6472-6477.
29. Wende A.R., Huss J.M., Schaeffer P.J., Giguere V., Kelly D.P. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol. Cell. Biol. 2005, 25:10684-10694.
30. Benton C.R., Nickerson J.G., Lally J., Han X.X., Holloway G.P., Glatz J.F., Luiken J.J., Graham T.E., Heikkila J.J., Bonen A. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J. Biol. Chem. 2008, 283:4228-4240.
31. Kelly T.J., Lerin C., Haas W., Gygi S.P., Puigserver P. GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation. J. Biol. Chem. 2009, 284:19945-19952.
32. Arany Z., Lebrasseur N., Morris C., Smith E., Yang W., Ma Y., Chin S., Spiegelman B.M. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 2007, 5:35-46.
33. Vega R.B., Huss J.M., Kelly D.P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 2000, 20:1868-1876.
34. Tiraby C., Hazen B.C., Gantner M.L., Kralli A. Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth. Cancer Res. 2011, 71:2518-2528.
35. Cartoni R., Leger B., Hock M.B., Praz M., Crettenand A., Pich S., Ziltener J.L., Luthi F., Deriaz O., Zorzano A., Gobelet C., Kralli A., Russell A.P. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 2005, 567:349-358.
36. Cho Y., Hazen B.C., Russell A.P., Kralli A. Peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1)- and Estrogen-related receptor (ERR)-induced regulator in muscle 1 (PERM1) is a tissue-specific regulator of oxidative capacity in skeletal muscle cells. J. Biol. Chem. 2013, 288:25207-25218.
37. Chaturvedi R.K., Adhihetty P., Shukla S., Hennessy T., Calingasan N., Yang L., Starkov A., Kiaei M., Cannella M., Sassone J., Ciammola A., Squitieri F., Beal M.F. Impaired PGC-1alpha function in muscle in Huntington's disease. Hum. Mol. Genet. 2009, 18:3048-3065.
38. Freyssenet D., Berthon P., Barthelemy J.C., Busso T., Geyssant A., Denis C. Energetic status and mitochondrial oxidative capacity of rat skeletal muscle in response to creatine analogue ingestion. Biochim. Biophys. Acta 1995, 1228:211-215.
39. Shoubridge E.A., Challiss R.A., Hayes D.J., Radda G.K. Biochemical adaptation in the skeletal muscle of rats depleted of creatine with the substrate analogue beta-guanidinopropionic acid. Biochem. J. 1985, 232:125-131.
40. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12017-12022.
41. Lee W.J., Kim M., Park H.S., Kim H.S., Jeon M.J., Oh K.S., Koh E.H., Won J.C., Kim M.S., Oh G.T., Yoon M., Lee K.U., Park J.Y. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem. Biophys. Res. Commun. 2006, 340:291-295.
42. Glover L.E., Bowers B.E., Saeedi B., Ehrentraut S.F., Campbell E.L., Bayless A.J., Dobrinskikh E., Kendrick A.A., Kelly C.J., Burgess A., Miller L., Kominsky D.J., Jedlicka P., Colgan S.P. Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:19820-19825.
43. Arany Z., Foo S.Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G., Cooper M., Laznik D., Chinsomboon J., Rangwala S.M., Baek K.H., Rosenzweig A., Spiegelman B.M. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008, 451:1008-1012.
44. Tremblay A.M., Dufour C.R., Ghahremani M., Reudelhuber T.L., Giguere V. Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol. Endocrinol. 2010, 24:22-32.
45. Charest-Marcotte A., Dufour C.R., Wilson B.J., Tremblay A.M., Eichner L.J., Arlow D.H., Mootha V.K., Giguere V. The homeobox protein Prox1 is a negative modulator of ERR{alpha}/PGC-1{alpha} bioenergetic functions. Genes Dev. 2010, 24:537-542.
46. Schmidt D., Wilson M.D., Ballester B., Schwalie P.C., Brown G.D., Marshall A., Kutter C., Watt S., Martinez-Jimenez C.P., Mackay S., Talianidis I., Flicek P., Odom D.T. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 2010, 328:1036-1040.
47. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 2003, 551:491-501.
48. Vescovo G., Ravara B., Gobbo V., Angelini A., Dalla Libera L. Skeletal muscle fibres synthesis in heart failure: role of PGC-1alpha, calcineurin and GH. Int. J. Cardiol. 2005, 104:298-306.
49. Remels A.H., Schrauwen P., Broekhuizen R., Willems J., Kersten S., Gosker H.R., Schols A.M. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur. Respir. J. 2007, 30:245-252.
50. Ling C., Poulsen P., Carlsson E., Ridderstrale M., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 2004, 114:1518-1526.
51. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
52. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., Defronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8466-8471.
53. Broqvist M., Dahlstrom U., Karlsson E., Larsson J. Muscle energy metabolism in severe chronic congestive heart failure-effect of treatment with enalapril. Eur. Heart J. 1992, 13:1217-1224.
54. Jakobsson P., Jorfeldt L., Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur. Respir. J. 1990, 3:192-196.
55. Wu F.Y., Tu H.J., Qin B., Chen T., Xu H.F., Qi J., Wang D.H. Value of dynamic (3)(1)P magnetic resonance spectroscopy technique in in vivo assessment of the skeletal muscle mitochondrial function in type 2 diabetes. Chin. Med. J. 2012, 125:281-286.
56. Sullivan M.J., Green H.J., Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990, 81:518-527.
57. Tecilazich F., Dinh T., Lyons T.E., Guest J., Villafuerte R.A., Sampanis C., Gnardellis C., Zuo C.S., Veves A. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. J. Vasc. Surg. 2013, 57:997-1005.
58. Ten Hove M., Chan S., Lygate C., Monfared M., Boehm E., Hulbert K., Watkins H., Clarke K., Neubauer S. Mechanisms of creatine depletion in chronically failing rat heart. J. Mol. Cell. Cardiol. 2005, 38:309-313.
59. Lygate C.A., Bohl S., ten Hove M., Faller K.M., Ostrowski P.J., Zervou S., Medway D.J., Aksentijevic D., Sebag-Montefiore L., Wallis J., Clarke K., Watkins H., Schneider J.E., Neubauer S. Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction. Cardiovasc. Res. 2012, 96:466-475.
60. Sihag S., Cresci S., Li A.Y., Sucharov C.C., Lehman J.J. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J. Mol. Cell. Cardiol. 2009, 46:201-212.